CSL Plasma Inc. announced it expects to complete the rollout of Haemonetics Corporation’s NexSys PCS devices with Persona PLUS technology and related disposables across all its current U.S. plasma collection centers by the end of calendar year 2027. This update follows a non-exclusive supply agreement entered into in August 2026. The scope and timing remain subject to change, and Haemonetics is not updating its fiscal 2027 guidance at this time. An update on the financial impact is expected during the second fiscal quarter earnings call in November 2026. Haemonetics Corporation develops and manufactures medical devices for blood management and plasma collection.
